USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
Carina R. Maier(German Cancer Research Center), Almut Schulze(German Cancer Research Center), Oliver Hartmann, Kevin Klann(Goethe University Frankfurt), Felix C. E. Vogel(German Cancer Research Center), Bastian Krenz(University of Würzburg), Martin Eilers(University of Würzburg), Markus E. Diefenbacher(FZI Research Center for Information Technology), Marco A. Calzado(Instituto Maimónides de Investigación Biomédica de Córdoba), Lisa Schlicker(German Cancer Research Center), Elias Einig(University of Tübingen), Viktoria Buck(Comprehensive Cancer Center Mainfranken), Werner Schmitz(University of Würzburg), Nikita Popov(University of Tübingen), Cristian Prieto‐Garcia(Goethe University Frankfurt), Mathias T. Rosenfeldt(University of Würzburg), Kamal M. Al-Shami(German Cancer Research Center), Silke Haid(German Cancer Research Center), Christian Münch(Goethe University Frankfurt)
Cited by 34
Related Papers
Lipid metabolism in cancer
|FEBS Journal|2012|1.3k
Myc’s broad reach
|Genes & Development|2008|922
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
|Nature Genetics|2016|495
FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression
|Cell Death and Differentiation|2011|312